Dexcom Inc (NASDAQ:DXCM) Sellers Increased By 0.89% Their Shorts As Of Jan 14, 2019

DexCom, Inc. (NASDAQ:DXCM) Corporate Logo

During Q3 2018 the big money sentiment increased to 1.31. That’s change of 0.09, from 2018Q2’s 1.22. 12 investors sold all, 107 reduced holdings as DexCom, Inc. ratio is positive. 72 grew holdings while 84 funds bought holdings. Funds hold 84.12 million shares thus 4.99% less from 2018Q2’s 88.54 million shares.
C A S invested 0.07% of its capital in DexCom, Inc. (NASDAQ:DXCM). The North Carolina-based Piedmont Advsrs has invested 0.04% in DexCom, Inc. (NASDAQ:DXCM). Cap Intll Investors holds 0.22% of its capital in DexCom, Inc. (NASDAQ:DXCM) for 3.33 million shs. Sei Invs invested in 77,019 shs. Proshare Advsrs Ltd Limited Liability Company reported 3,119 shs. Assetmark reported 276 shs or 0% of all its holdings. Broadfin Limited Liability Co reported 24,200 shs. Principal Fin Grp invested in 0.01% or 59,955 shs. Cambridge Investment Research Inc stated it has 0.01% of its capital in DexCom, Inc. (NASDAQ:DXCM). First Trust L P owns 0.08% invested in DexCom, Inc. (NASDAQ:DXCM) for 283,132 shs. Parametric Portfolio Lc owns 210,359 shs. Amundi Pioneer Asset Management stated it has 0.03% in DexCom, Inc. (NASDAQ:DXCM). Wells Fargo Mn owns 0.03% invested in DexCom, Inc. (NASDAQ:DXCM) for 661,295 shs. Stevens Cap Management Lp holds 0.14% or 27,274 shs. Fincl Architects holds 0% of its capital in DexCom, Inc. (NASDAQ:DXCM) for 100 shs.

DexCom, Inc. had 43 selling transactions and 0 insider buys since July 16, 2018. This’s net activity of $37.65 million. ALTMAN STEVEN R sold $292,593 worth of DexCom, Inc. (NASDAQ:DXCM) on Wednesday, January 2. The insider Pacelli Steven Robert sold 5,483 shs worth $788,210. FOLETTA MARK G also sold $137,503 worth of DexCom, Inc. (NASDAQ:DXCM) on Friday, August 24. 10,000 shs valued at $995,561 were sold by GREGG TERRANCE H on Monday, July 16. $48,760 worth of DexCom, Inc. (NASDAQ:DXCM) was sold by Murphy Patrick Michael on Monday, December 10. ACE HEATHER S sold $263,360 worth of stock or 1,832 shs.

It was showed an increase on Dexcom Inc (NASDAQ:DXCM)’s short interest with 0.89%. In January was published DXCM’s total 4.67M short interest by FINRA. That’s 0.89% up from 4.63 million shares. Dexcom Inc (NASDAQ:DXCM) has 1.66 million shares average volume. It’ll cost 3 days for DXCM to restore its former position.

DXCM is hitting $142.95 during the last trading session, after increased 1.31%.DexCom, Inc. has volume of 849,044 shares. Since January 14, 2018 DXCM has risen 105.85% and is uptrending. DXCM outperformed by 105.85% the S&P500.

DexCom, Inc., a medical device company, together with its subsidiaries, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally.The firm is valued at $12.70 billion. The firm offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes.The P/E ratio is 295.35. The Company’s products include DexCom G4 PLATINUM system for continuous use by adults with diabetes; DexCom G4 PLATINUM with Share, a remote monitoring system; and DexCom G5 Mobile, a CGM system that directly communicates to a patientÂ’s mobile and its data can be integrated with DexCom CLARITY, which is a next generation cloud reporting software for personalized, easy-to-understand analysis of trends to improve diabetes management.

DexCom, Inc. (NASDAQ:DXCM) Ratings Coverage

In total 11 analysts cover DexCom (NASDAQ:DXCM). “Buy” rating has 7, “Sell” are 0, while 4 are “Hold”. 64% are bullish. 17 are the (NASDAQ:DXCM)’s analyst reports since August 2, 2018 according to StockzIntelligence Inc. On Thursday, August 23 the stock has “Overweight” rating by Stephens. On Friday, August 3 Morgan Stanley maintained DexCom, Inc. (NASDAQ:DXCM) with “Equal-Weight” rating. On Wednesday, September 12 the firm earned “Market Perform” rating by Northland Capital. On Thursday, October 11 the firm has “Equal-Weight” rating given by Morgan Stanley. On Wednesday, August 15 the stock of DexCom, Inc. (NASDAQ:DXCM) has “Buy” rating given by Bank of America. On Thursday, August 2 the rating was maintained by Canaccord Genuity with “Buy”. On Tuesday, October 23 the company was maintained by Raymond James. The company rating was upgraded by Berenberg on Monday, August 6. On Thursday, August 2 the rating was maintained by Bank of America with “Buy”. In Thursday, August 2 report Jefferies maintained the stock with “Buy” rating.

DexCom, Inc. (NASDAQ:DXCM) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.